{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,9,8]],"date-time":"2024-09-08T09:39:39Z","timestamp":1725788379685},"reference-count":12,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[1986,3,1]],"date-time":"1986-03-01T00:00:00Z","timestamp":510019200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[1986,3,1]],"date-time":"1986-03-01T00:00:00Z","timestamp":510019200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Invest New Drugs"],"published-print":{"date-parts":[[1986,3]]},"DOI":"10.1007\/bf00172014","type":"journal-article","created":{"date-parts":[[2004,8,15]],"date-time":"2004-08-15T08:39:12Z","timestamp":1092559152000},"page":"39-42","source":"Crossref","is-referenced-by-count":15,"title":["Phase II trial with oral idarubicin in advanced breast cancer"],"prefix":"10.1007","volume":"4","author":[{"given":"Massimo","family":"Lopez","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luigi","family":"Di Lauro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paola","family":"Papaldo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bonaventura","family":"Lazzaro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fabrizio","family":"Ganzina","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicola","family":"Di Pietro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"BF00172014_CR1","first-page":"829","volume":"60","author":"F Arcamone","year":"1974","unstructured":"Arcamone F, Bernardi L, Giardino P, Patelli B, Di Marco A, Casazza AM, Pratesi P: Synthesis and antitumor activity of 4-demethoxydaunorubicin, 4-demethoxy-7,9-diepidaunorubicin, and their \u03b2 anomers. Cancer Treat Rep 60:829\u2013834, 1974","journal-title":"Cancer Treat Rep"},{"key":"BF00172014_CR2","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1177\/030089168006600503","volume":"66","author":"AM Casazza","year":"1980","unstructured":"Casazza AM, Pratesi G, Giuliani F, Di Marco A: Antileukemic activity of 4-demethoxydaunorubicin in mice. Tumori 66:549\u2013564, 1980","journal-title":"Tumori"},{"key":"BF00172014_CR3","first-page":"893","volume":"61","author":"A Di Marco","year":"1977","unstructured":"Di Marco A, Casazza AM, Pratesi G: Antitumor activity of 4-demethoxydaunorubicin administered orally. Cancer Treat Rep 61:893\u2013895, 1977","journal-title":"Cancer Treat Rep"},{"key":"BF00172014_CR4","first-page":"193","volume-title":"Anthracyclines and Cancer Therapy","author":"FC Giuliani","year":"1983","unstructured":"Giuliani FC, Spreafico F, Casazza AM: Preclinical studies on new anthracyclines: antitumor, toxicologic and pharmacologic properties. In: Hansen HH (ed): Anthracyclines and Cancer Therapy. Excerpta Medica, Amsterdam, 1983, pp 193\u2013207"},{"key":"BF00172014_CR5","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1007\/BF00172075","volume":"1","author":"V Bonfante","year":"1983","unstructured":"Bonfante V, Ferrari L, Villani F, Bonadonna G: Phase I study of 4-demethoxydaunorubicin. Invest N Drugs 1:161\u2013168, 1983","journal-title":"Invest N Drugs"},{"key":"BF00172014_CR6","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1016\/0277-5379(82)90133-X","volume":"18","author":"S Kaplan","year":"1982","unstructured":"Kaplan S, Martini A, Varini M, Togni P, Cavalli F: Phase I trial of 4-demethoxydaunorubicin with single i.v. doses. Eur J Cancer Clin Oncol 18:1303\u20131306, 1982","journal-title":"Eur J Cancer Clin Oncol"},{"key":"BF00172014_CR7","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1177\/030089168306900605","volume":"69","author":"G Lambertenghi-Deliliers","year":"1983","unstructured":"Lambertenghi-Deliliers G, Pogliani E, Maiolo AT, Pacciarini MA, Polli EE: Therapeutic activity of 4-demethoxy-daunorubicin (idarubicin) in adult acute leukemia. Tumori 69:515\u2013519, 1983","journal-title":"Tumori"},{"key":"BF00172014_CR8","unstructured":"Rozencweig M, Piccart M, Beer M, Kaplan S, Cavalli F, Bonfante V, Bonadonna G: Phase I trials with oral 4-demethoxydaunorubicin. Proc 13th International Congress of Chemotherapy, Vienna, Austria, Aug\u2013Sept 1983, Part 215, pp 45\u201347"},{"key":"BF00172014_CR9","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1002\/1097-0142(19810101)47:1<207::AID-CNCR2820470134>3.0.CO;2-6","volume":"47","author":"AB Miller","year":"1981","unstructured":"Miller AB, Hoogstraten B, Staquet M, Winkler A: Reporting results of cancer treatment. Cancer 47:207\u2013214, 1981","journal-title":"Cancer"},{"key":"BF00172014_CR10","first-page":"117","volume-title":"Breast Cancer Management \u2014 Early and Late","author":"DC Tormey","year":"1977","unstructured":"Tormey DC, Neifeld JP: Chemotherapeutic approaches to disseminated disease. In: Stoll BA (ed): Breast Cancer Management \u2014 Early and Late. William Heinemann Medical Books, London, 1977, pp 117\u2013131"},{"key":"BF00172014_CR11","first-page":"21","volume-title":"International Symposium on Advances in Anthracycline Chemotherapy","author":"G Bonadonna","year":"1984","unstructured":"Bonadonna G: Adriamycin vs epirubicin in advanced breast cancer (Abstract). International Symposium on Advances in Anthracycline Chemotherapy: Epirubicin. Milan, June 1984, p 21"},{"key":"BF00172014_CR12","first-page":"949","volume":"67","author":"CJ Coonley","year":"1983","unstructured":"Coonley CJ, Warrel RP, Strauss DJ, Young CW: Clinical evaluation of 4-Demethoxydaunorubicin in patients with advanced malignant lymphomas. Cancer Treat Rep 67:949\u2013950, 1983","journal-title":"Cancer Treat Rep"}],"container-title":["Investigational New Drugs"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF00172014\/fulltext.html","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/BF00172014.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/BF00172014\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF00172014","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/BF00172014.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,11]],"date-time":"2023-03-11T18:31:02Z","timestamp":1678559462000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/BF00172014"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1986,3]]},"references-count":12,"journal-issue":{"issue":"1","published-print":{"date-parts":[[1986,3]]}},"alternative-id":["BF00172014"],"URL":"https:\/\/doi.org\/10.1007\/bf00172014","relation":{},"ISSN":["0167-6997","1573-0646"],"issn-type":[{"value":"0167-6997","type":"print"},{"value":"1573-0646","type":"electronic"}],"subject":[],"published":{"date-parts":[[1986,3]]}}}